DS
MNOV icon

DRW Securities’s MediciNova MNOV Stock Holding History

DRW Securities’s Portfolio MNOV Stock Details MNOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,800
Closed -$821K – 1576
2025
Q4 		$821K Buy
+3,800
New +$5.24K 0.02% 350

Other funds holding MNOV

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

DRW Securities's MNOV Position: Q1 2026 in Review

DRW Securities sold out of MediciNova (MNOV) in Q1 2026, closing a stake of 3,800 shares — an estimated $821K sold.

DRW Securities first reported a position in MNOV in Q4 2025 and held it in 1 quarter. The position peaked at $821K in Q4 2025. 30 funds tracked by Wall St. Rank hold MNOV as of Q1 2026.

  • DRW Securities reported no remaining MediciNova position as of Q1 2026 after selling out during the quarter.
  • DRW Securities sold 3,800 MediciNova shares in Q1 2026, an estimated $821K.
  • DRW Securities first reported a position in MediciNova in Q4 2025 and held it in 1 quarter.
  • DRW Securities's MediciNova position peaked at $821K in Q4 2025.
  • 30 funds tracked by Wall St. Rank held MediciNova as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.